Main > A1. CORP. INDEX. H-Hm > Hemosonics LLC./P C2



Hemosonics LLC./P C2's subsections
2014. 08.05. Pres. & CEO
2017. 05.30. Acq. By Stago Group
2019. 03.13. FDA de novo
2019. 09.10. CE Mark
2022. 11.30. FDA 510(k) CLEARANCE
Web-Site

Hemosonics LLC./P C2's products
This section has no products